Diabetes and endometrial cancer: Effect modification by body weight, physical activity and hypertension

British Journal of Cancer

Volumn 97, Issue 7, 2007, Pages 995-998

  Lucenteforte, E ^a   Bosetti, C ^a   Talamini, R ^b   Montella, M ^c   Zucchetto, A ^b   Pelucchi, C ^a   Franceschi, S ^d   Negri, E ^a   Levi, F ^e   Vecchia, C La ^a,f  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Body mass index; Case control study; Diabetes; Endometrial cancer; Hypertension; Physical activity

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CANCER RISK; CONTROLLED STUDY; DIABETES MELLITUS; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MENOPAUSE; OBESITY; PARITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BODY WEIGHT; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIABETES COMPLICATIONS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; ITALY; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; SWITZERLAND;

EID: 34948812450     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603933     Document Type: Article

References (22)

1. Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA, Lazovich D, Folsom AR (2001) Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 10: 611-616
2. Augustin LS, Dal Maso L, Franceschi S, Talamini R, Kendall CW, Jenkins DJ, Vidgen E, La Vecchia C (2004) Association between components of the insulin-like growth factor system and endometrial cancer risk. Oncology 67: 54-59
3. Augustin LS, Gallus S, Bosetti C, Levi F, Negri E, Franceschi S, Dal Maso L, Jenkins DJ, Kendall CW, La Vecchia C (2003) Glycemic index and glycemic load in endometrial cancer. Int J Cancer 105: 404-407
4. Bosetti C, Tavani A, Negri E, Trichopoulos D, La Vecchia C (2001) Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls. J Clin Epidemiol 54: 902-906
5. Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lannom L, Hoover RN (1992) Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 167: 1317-1325
6. Calle C, Campion J, Garcia-Arencibia M, Maestro B, Davila N (2003) Transcriptional inhibition of the human insulin receptor gene by aldosterone. J Steroid Biochem Mol Biol 84: 543-553
7. Cook LS, Weiss NS, Doherty JA, Chen C (2006) Endometrial cancer. In: Schottenfeld D, Fraumeni Jr JF (eds). Cancer epidemiology and prevention, pp 1027-1043. New York: Oxford University Press
8. Cust AE, Armstrong BK, Friedenreich CM, Slimani N, Bauman A (2007) Physical activity and endometrial cancer risk: a review of the current evidence, biologic mechanisms and the quality of physical activity assessment methods. Cancer Causes Control 18: 243-258
9. Dal Maso L, Augustin LS, Karalis A, Talamini R, Franceschi S, Trichopoulos D, Mantzoros CS, La Vecchia C (2004) Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 89: 1160-1163
10. Friberg E, Mantzoros CS, Wolk A (2007) Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev 16: 276-280
11. La Vecchia C, Decarli A, Franceschi S, Ferraroni M, Pagano R (1995) Prevalence of chronic diseases in alcohol abstainers. Epidemiology 6: 436-438
12. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70: 950-953
13. Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB (2005) Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 90: 4542-4548
14. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG (1991) A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72: 83-89
15. Parazzini F, La Vecchia C, Bocciolone L, Franceschi S (1991) The epidemiology of endometrial cancer. Gynecol Oncol 41: 1-16
16. Parazzini F, La Vecchia C, Negri E, Riboldi GL, Surace M, Benzi G, Maina A, Chiaffarino F (1999) Diabetes and endometrial cancer: an Italian case-control study. Int J Cancer 81: 539-542
17. Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, Escudero-De los Rios P, Salmeron-Castro J, Larrea F, Hernandez-Avila M (2000) Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 11: 707-711
18. Sharma DN, Chander S, Gairola M, Kumar L, Parida DK, Pathy S (2001) Medical disorders associated with endometrial carcinoma. J Assoc Physicians India 49: 630-633
19. Shoff SM, Newcomb PA (1998) Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol 148: 234-240
20. Voskuil DW, Monninkhof EM, Elias SG, Vlems FA, van Leeuwen FE (2007) Physical activity and endometrial cancer risk, a systematic review of current evidence. Cancer Epidemiol Biomarkers Prev 16: 639-648
21. Weiderpass E, Brismar K, Bellocco R, Vainio H, Kaaks R (2003) Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk. Br J Cancer 89: 1697- 1704
22. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA (2000) Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 11: 185-192